Roberto Spreafico

Roberto Spreafico

Auto-generated profile, based on publicly available information

Roberto Spreafico

Epilepsy Unit Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy

Research Focus & Metrics

Academic Career Length

53Years (1974-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 November 2010 in Epilepsia
Verified
Journal Article
Open access
PDF file
IBIngmar Blumcke
Ingmar Blumcke
MTMaria Thom
Maria Thom
EAEleonora Aronica
Eleonora Aronica
DADawna D. Armstrong
Dawna D. Armstrong
HVHarry V. Vinters
Harry V. Vinters
RSRoberto Spreafico
Roberto Spreafico
Purpose: Focal cortical dysplasias (FCD) are localized regions of malformed cerebral cortex and are very frequently associated with epilepsy in both children and adults. A broad spectrum of histopathology has been included in the diagnosis of FCD. An ILAE task force proposes an international consensus classification system to better characterize specific clinicopathological FCD entities. Methods: Thirty‐two Task Force members have reevaluated available data on electroclinical presentation, imaging, neuropathological examination of surgical specimens as well as postsurgical outcome. Key Findings: The ILAE Task Force proposes a three‐tiered classification system. FCD Type I refers to isolated lesions, which present either as radial (FCD Type Ia) or tangential (FCD Type Ib) dyslamination of the neocortex, microscopically identified in one or multiple lobes. FCD Type II is an isolated lesion characterized by cortical dyslamination and dysmorphic neurons without (Type IIa) or with balloon cells (Type IIb). Hence, the major change since a prior classification represents the introduction of FCD Type III, which occurs in combination with hippocampal sclerosis (FCD Type IIIa), or with epilepsy‐associated tumors (FCD Type IIIb). FCD Type IIIc is found adjacent to vascular malformations, whereas FCD Type IIId can be diagnosed in association with epileptogenic lesions acquired in early life (i.e., traumatic injury, ischemic injury or encephalitis). Significance: This three‐tiered classification system will be an important basis to evaluate imaging, electroclinical features, and postsurgical seizure control as well as to explore underlying molecular pathomechanisms in FCD.

20 May 2013 in Epilepsia
Verified
Journal Article
Open access
PDF file
IBIngmar Blumcke
Ingmar Blumcke
MTMaria Thom
Maria Thom
EAEleonora Aronica
Eleonora Aronica
DADawna D. Armstrong
Dawna D. Armstrong
FBFabrice Bartolomei
Fabrice Bartolomei
RSRoberto Spreafico
Roberto Spreafico
Summary: Hippocampal sclerosis (HS) is the most frequent histopathology encountered in patients with drug‐resistant temporal lobe epilepsy (TLE). Over the past decades, various attempts have been made to classify specific patterns of hippocampal neuronal cell loss and correlate subtypes with postsurgical outcome. However, no international consensus about definitions and terminology has been achieved. A task force reviewed previous classification schemes and proposes a system based on semiquantitative hippocampal cell loss patterns that can be applied in any histopathology laboratory. Interobserver and intraobserver agreement studies reached consensus to classify three types in anatomically well‐preserved hippocampal specimens:HSInternational League Against Epilepsy (ILAE) type 1 refers always to severe neuronal cell loss and gliosis predominantly inCA1 andCA4 regions, compared toCA1 predominant neuronal cell loss and gliosis (HS ILAEtype 2), orCA4 predominant neuronal cell loss and gliosis (HS ILAEtype 3). Surgical hippocampus specimens obtained from patients withTLEmay also show normal content of neurons with reactive gliosis only (no‐HS).HS ILAEtype 1 is more often associated with a history of initial precipitating injuries before age 5 years, with early seizure onset, and favorable postsurgical seizure control.CA1 predominantHS ILAEtype 2 andCA4 predominantHS ILAEtype 3 have been studied less systematically so far, but some reports point to less favorable outcome, and to differences regarding epilepsy history, including age of seizure onset. The proposed international consensus classification will aid in the characterization of specific clinicopathologic syndromes, and explore variability in imaging and electrophysiology findings, and in postsurgical seizure control.

23 March 2004 in Neurology
Verified
Journal Article
Closed access
APA. Palmini
A. Palmini
INImad Najm
Imad Najm
GAG. Avanzini
G. Avanzini
TBT. Babb
T. Babb
RGR. Guerrini
R. Guerrini
HVH. V. Vinters
H. V. Vinters
Background: There have been difficulties in achieving a uniform terminology in the literature regarding issues of classification with respect to focal cortical dysplasias (FCDs) associated with epilepsy. Objectives: To review and refine the current terminology and classification issues of potential clinical relevance to epileptologists, neuroradiologists, and neuropathologists dealing with FCD. Methods: A panel discussion of epileptologists, neuropathologists, and neuroradiologists with special expertise in FCD was held. Results: The panel proposed 1) a specific terminology for the different types of abnormal cells encountered in the cerebral cortex of patients with FCD; 2) a reappraisal of the different histopathologic abnormalities usually subsumed under the term “microdysgenesis,” and suggested that this terminology be abandoned; and 3) a more detailed yet straightforward classification of the various histopathologic features that usually are included under the heterogeneous term of “focal cortical dysplasia.” Conclusion: The panel hopes that these proposals will stimulate the debate toward more specific clinical, imaging, histopathologic, and prognostic correlations in patients with FCD associated with epilepsy.

1 August 2002 in Brain
Verified
Journal Article
Open access
PDF file
LTL. Tassi
L. Tassi
NCN. Colombo
N. Colombo
RGR. Garbelli
R. Garbelli
SFS. Francione
S. Francione
GRG. Lo Russo
G. Lo Russo
RSR. Spreafico
R. Spreafico
Since the original description by Taylor, the term focal cortical dysplasia has been used to refer to a wide range of alterations of the cortical mantle. More recently, these conditions have been described from neuroimaging, neuropathological and genetic standpoints, generating several classifications. It is widely recognized that these classifications are unsatisfactory. We propose a simplified classification of focal cortical dysplasias based on easily recognized neuropathological characteristics. We retrospectively re‐examined histological sections of cortex from 52 of 224 (23%) patients operated on for drug‐resistant partial epilepsy in which cortical dysplasia was present but not associated with other brain pathologies except hippocampal sclerosis. Three subgroups were identified: (i) architectural dysplasia (31 patients) characterized by abnormal cortical lamination and ectopic neurones in white matter; (ii) cytoarchitectural dysplasia (six patients) characterized by giant neurofilament‐enriched neurones in addition to altered cortical lamination; and (iii) Taylor‐type cortical dysplasia (15 patients) with giant dysmorphic neurones and balloon cells (all but two patients) associated with cortical laminar disruption. The patients with architectural dysplasia had lower seizure frequency than those with cytoarchitectural and Taylor‐type dysplasia, and the epileptogenic zone was mainly in the temporal lobe. In patients with Taylor‐type dysplasia, the epileptogenic zone was mainly extratemporal, and interictal stereo‐EEG was distinctive. MRI was unrevealing in 34% of patients, but distinctive signal alterations characterized most patients with Taylor‐type dysplasia, while focal hypoplasia with MRI abnormalities was found in architectural dysplasia. Patients with Taylor‐type dysplasia had the best outcome, with 75% seizure‐free (Engel class Ia) after at least a year of follow‐up compared with 50% of cytoarchitectural dysplasia and 43% of architectural dysplasia patients seizure‐free. This three‐category classification is based on easily recognized histopathological characteristics and avoids complicated terminology, while the distinctive ensemble of other characteristics defines clinically homogeneous groups.

5 January 2005 in Brain
Verified
Journal Article
Open access
PDF file
CBC. G. Bien
C. G. Bien
TGTiziana Granata
Tiziana Granata
CAC. Antozzi
C. Antozzi
JCJ. H. Cross
J. H. Cross
ODO. Dulac
O. Dulac
CEC. E. Elger
C. E. Elger
Rasmussen encephalitis (RE) is a rare but severe immune-mediated brain disorder leading to unilateral hemispheric atrophy, associated progressive neurological dysfunction and intractable seizures. Recent data on the pathogenesis of the disease, its clinical and paraclinical presentation, and therapeutic approaches are summarized. Based on these data, we propose formal diagnostic criteria and a therapeutic pathway for the management of RE patients.

1 December 1998 in Trends in Neurosciences
Verified
Journal Article
Closed access
MCMarco R Celio
Marco R Celio
RSRoberto Spreafico
Roberto Spreafico
SBSilvia De Biasi
Silvia De Biasi
LVLaura Vitellaro-Zuccarello
Laura Vitellaro-Zuccarello